GALT - Galectin Therapeutics GAAP EPS of -$0.15 August, 14 2023 09:29 AM Galectin Therapeutics Inc. 2023-08-14 09:29:20 ET Galectin Therapeutics press release ( NASDAQ: GALT ): Q2 GAAP EPS of -$0.15. Cash and cash equivalents of $17.97m For further details see: Galectin Therapeutics GAAP EPS of -$0.15